Prostaglandin E1 for preventing the progress of pulmonary arterial hypertension in rat model
Pulmonary artery hypertension (PAH) is a progressive chronic disease with a high mortality rate. Increased pulmonary vascular resistance and over-proliferation of pulmonary artery endothelial cells lead to remodeling of pulmonary vasculature. Several anti-PAH therapies targeting various pathways inv...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Atlantis Press
2018-05-01
|
Series: | Artery Research |
Subjects: | |
Online Access: | https://www.atlantis-press.com/article/125924946/view |